Inventor · disambiguated record
Stephen Macmahon
Also filed as: MACMAHON STEPHEN
7 granted patents·13 pending applications·23 citations·filing 2009–2025
84Inventor score
Top patents by PatentIndex Score
20 records- 0192US12102623B2Compositions for the treatment of hypertensionTHE GEORGE INST FOR GLOBAL HEALTH·Filed 2022·Granted Oct 1, 2024·3 cites·12 claims
- 0292US11478462B2Compositions for the treatment of hypertensionTHE GEORGE INST FOR GLOBAL HEALTH·Filed 2020·Granted Oct 25, 2022·4 cites·20 claims
- 0391US12285415B2Compositions for the treatment of hypertensionTHE GEORGE INST FOR GLOBAL HEALTH·Filed 2023·Granted Apr 29, 2025·2 cites·12 claims
- 0491US10799487B2Compositions for the treatment of hypertensionTHE GEORGE INST FOR GLOBAL HEALTH·Filed 2019·Granted Oct 13, 2020·7 cites·20 claims
- 0590US10322117B2Compositions for the treatment of hypertensionTHE GEORGE INST FOR GLOBAL HEALTH·Filed 2018·Granted Jun 18, 2019·6 cites·8 claims
- 0678US12465599B2Compositions for the treatment of hypertensionTHE GEORGE INST FOR GLOBAL HEALTH·Filed 2025·Granted Nov 11, 2025·0 cites·16 claims
- 0774US11033544B2Low-dose triple combination formulationTHE GEORGE INST FOR GLOBAL HEALTH·Filed 2019·Granted Jun 15, 2021·1 cites·15 claims
- 0871US2022226316A1Synergistic combinations and methods of useTHE GEORGE INST FOR GLOBAL HEALTH·Filed 2021·Application pending·0 cites
- 0971US2022226317A1Synergistic combinations and methods of useTHE GEORGE INST FOR GLOBAL HEALTH·Filed 2021·Application pending·0 cites
- 1071US2022226315A1Synergistic combinations and methods of useTHE GEORGE INST FOR GLOBAL HEALTH·Filed 2021·Application pending·0 cites
- 1169US2021260056A1Low-dose triple combination formulationTHE GEORGE INST FOR GLOBAL HEALTH·Filed 2021·Application pending·0 cites
- 1266US2023125076A1Compositions for the treatment of hypertensionTHE GEORGE INST FOR GLOBAL HEALTH·Filed 2022·Application pending·0 cites
- 1365US2010099091A1Genetic component of complications in type 2 diabetesHAMET PAVEL·Filed 2009·Application pending·0 cites
- 1465US2010136540A1Methods and compositions for characterizing patients for clinical outcome trialsHAMET PAVEL·Filed 2009·Application pending·0 cites
- 1565US2011158979A1Genetic component of complications in type 2 diabetesPROGNOMIX INC·Filed 2009·Application pending·0 cites
- 1659US2020030296A1Compositions for the treatment of hypertensionTHE GEORGE INST FOR GLOBAL HEALTH·Filed 2019·Application pending·0 cites
- 1747US2022184070A1Low-dose triple combination formulationTHE GEORGE INST FOR GLOBAL HEALTH·Filed 2020·Application pending·0 cites
- 1840US2014023635A1Single nucleotide polymorphisms and genes associated with t2d-related complicationsHAMET PAVEL·Filed 2011·Application pending·0 cites
- 1937US2012065075A1Method of determining a predisposition to atrial fibrillation (af) in a subjectHAMET PAVEL·Filed 2011·Application pending·0 cites
- 2032US2012134981A1Genes linking several complications of type-2 diabetes (t2d)HAMET PAVEL·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen Macmahon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →